available for iOS, Android & web
December 11, 2015
April 06, 2015
March 06, 2015
February 11, 2015
December 08, 2014
June 24, 2014
Inks deal with Dimension Therapeutics
April 15, 2013
The venture capital arm of Boehringer Ingelheim has made an equity investment into France's Eyevensys, which has developed a new process for non-viral gene therapy using electrotransfer that produces proteins for the treatment of ocular disease
November 04, 2012
European regulators have given the green light to UniQure's Glybera, which makes it the first gene therapy to be approved in the western world
July 23, 2012
Much excitement has greeted the news that European regulators have finally recommended approval of Glybera, which should make it the first gene therapy to be approved in the western world
March 20, 2012
A £3.1 million award from the Medical Research Council (MRC) and the National Institute for Health Research (NIHR) will enable a UK consortium to move ahead with efficacy testing of its inhaled gene therapy for cystic fibrosis.
Recruitment agencies provide the unique bridge to [more]...
International Clinical Researcher of the Year 2016
Book your tickets today!
PharmaTimes 2015 Copyright | RSS Feed Subscriptions